Back to Browse Journals » Vascular Health and Risk Management » Volume 4 » Issue 4

Characterizing blood microparticles: Technical aspects and challenges

Authors Arun S Shet

Published Date September 2008 Volume 2008:4(4) Pages 769—774

DOI http://dx.doi.org/10.2147/VHRM.S955

Published 4 September 2008

Arun S Shet

Department of Medicine, St. Johns Medical College and Hospital, St. Johns National Academy of Health Sciences, Bangalore, India

Abstract: Although long considered to be cellular debris, microparticles (MPs) are more recently considered refl ective of cellular stimulation, activation, and degeneration/apoptosis. MPs that arise from the cellular components of blood and the endothelial lining of blood vessels are referred to as blood MPs and by general consensus are small (≤1.5 μm), expose the anionic phospholipid (PL) phosphatidylserine (PS) on the outer leaflet of their membrane, and bear surface membrane antigens refl ecting their cellular origin. This brief review summarizes the different approaches used by several groups to study blood MPs. The aim of this article is to review the technical aspects of characterizing the morphological and functional properties of blood MPs with emphasis on the preanalytical and analytical variables involved in these studies.

Keywords: microparticles, flow cytometry, techniques

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Cancer stem cells in head and neck cancer

Allegra E, Trapasso S

OncoTargets and Therapy 2012, 5:375-383

Published Date: 21 November 2012

Reduced reward-related probability learning in schizophrenia patients

Yılmaz A, Simsek F, Gonul AS

Neuropsychiatric Disease and Treatment 2012, 8:27-34

Published Date: 5 January 2012

Clinical profile of hypertension at a University Teaching Hospital in Nigeria

Arthur C Onwuchekwa, Sunday Chinenye

Vascular Health and Risk Management 2010, 6:511-516

Published Date: 1 July 2010

Potential bias in ophthalmic pharmaceutical clinical trials

Paul Varner

Clinical Ophthalmology 2008, 2:401-411

Published Date: 30 June 2008

Peripapillary detachment in pathologic myopia: Unusual OCT findings

Michele Carbonelli, Giacomo Savini, Maurizio Zanini, Piero Barboni
Centro Salus, Bologna, Italy

Clinical Ophthalmology 2007, 1:327-329

Published Date: 3 December 2007

Fifty years chlorpromazine: a historical perspective

Thomas A Ban

Neuropsychiatric Disease and Treatment 2007, 3:495-500

Published Date: 8 October 2007

Continuous levodopa for advanced Parkinson’s disease

Christofer Lundqvist

Neuropsychiatric Disease and Treatment 2007, 3:335-348

Published Date: 13 August 2007

Short-term effect of the HMG-CoA reductase inhibitor rosuvastatin on erythrocyte nitric oxide synthase activity

Barbara Ludolph, Wilhelm Bloch, Malte Kelm, Rainer Schulz, Petra Kleinbongard

Vascular Health and Risk Management 2007, 3:1069-1073

Published Date: 15 January 2007

A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications

Behzad Molavi, Negah Rassouli, Suveer Bagwe, Neda Rasouli

Vascular Health and Risk Management 2007, 3:967-973

Published Date: 15 January 2007